These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 10117547)

  • 1. Abbott terms hospital products market 'soft'.
    Wagner M
    Mod Healthc; 1992 Apr; 22(16):16. PubMed ID: 10117547
    [No Abstract]   [Full Text] [Related]  

  • 2. Big discounts mask high profits in solutions market dominated by Travenol and Abbott.
    Hosp Purch Manage; 1978 Oct; 3(10):3-9. PubMed ID: 10238751
    [No Abstract]   [Full Text] [Related]  

  • 3. Buying groups tell drug prices.
    Kuntz E
    Mod Healthc; 1981 May; 11(5):50-1. PubMed ID: 10251545
    [No Abstract]   [Full Text] [Related]  

  • 4. Generic drug prices may rise 8-10%.
    Hosp Mater Manage; 1991 Feb; 16(2):1, 8-9. PubMed ID: 10109544
    [No Abstract]   [Full Text] [Related]  

  • 5. Best drug prices won nationally.
    Kuntz E
    Mod Healthc; 1980 Oct; 10(10):28-9. PubMed ID: 10248725
    [No Abstract]   [Full Text] [Related]  

  • 6. Vendor competition, generic drugs spur drop in pharmaceutical prices.
    Seigner CA
    Mod Healthc; 1985 Oct; 15(21):56, 60-2. PubMed ID: 10317662
    [No Abstract]   [Full Text] [Related]  

  • 7. Antibiotics prices continue to slide, while penicillins turn upward in 2nd quarter '88.
    Hosp Mater Manage; 1988 Oct; 13(10):13. PubMed ID: 10290136
    [No Abstract]   [Full Text] [Related]  

  • 8. The problems with solutions.
    Hosp Purch Manage; 1982 Oct; 7(10):12-5. PubMed ID: 10257089
    [No Abstract]   [Full Text] [Related]  

  • 9. Revisiting the solution market.
    Hosp Purch Manage; 1981 Jan; 6(1):3-7. PubMed ID: 10249378
    [No Abstract]   [Full Text] [Related]  

  • 10. By the numbers. Suppliers/purchasing.
    Mod Healthc; 2007 Dec; Suppl():70, 72, 74 passim. PubMed ID: 18220137
    [No Abstract]   [Full Text] [Related]  

  • 11. Cephalosporin prices climb at slower rate in 1992.
    Barlow RD
    Hosp Mater Manage; 1992 Jul; 17(7):1, 12-3. PubMed ID: 10119968
    [No Abstract]   [Full Text] [Related]  

  • 12. Groups dicker for price breaks as anesthetic gas goes multi-source.
    Werner C
    Hosp Mater Manage; 1993 Apr; 18(4):1, 9. PubMed ID: 10125354
    [No Abstract]   [Full Text] [Related]  

  • 13. Abbott, 3M form purchasing venture.
    Carter K
    Mod Healthc; 1987 Oct; 17(21):16. PubMed ID: 10284322
    [No Abstract]   [Full Text] [Related]  

  • 14. Collateral damage. Providers face negative fallout from the war on drugmakers.
    Taylor M
    Mod Healthc; 2001 Jun; 31(24):30-3. PubMed ID: 11430166
    [No Abstract]   [Full Text] [Related]  

  • 15. Cephalosporin prices rise 2.5% as groups buy bundled products.
    Litsikas M
    Hosp Mater Manage; 1989 May; 14(5):10-1. PubMed ID: 10292997
    [No Abstract]   [Full Text] [Related]  

  • 16. Drug prices advance 1%.
    Hosp Purch Manage; 1985 Nov; 10(11):16-7. PubMed ID: 10274489
    [No Abstract]   [Full Text] [Related]  

  • 17. I.V. prices drop as competition to win key purchasing groups intensifies.
    Fine J
    Mod Healthc; 1986 Jun; 16(13):36. PubMed ID: 10276952
    [No Abstract]   [Full Text] [Related]  

  • 18. Emergency treatment for hospital sales training.
    Maurer T
    Med Mark Media; 1982 Oct; 17(10):114-24. PubMed ID: 10257969
    [No Abstract]   [Full Text] [Related]  

  • 19. LyphoMed hopes to put troubles behind it.
    Wagner M
    Mod Healthc; 1989 Jan; 19(2):57. PubMed ID: 10291291
    [No Abstract]   [Full Text] [Related]  

  • 20. Hospital campaign against drug price increases is making a dent.
    Wagner M
    Mod Healthc; 1992 Mar; 22(10):30. PubMed ID: 10116546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.